Burden of respiratory comorbidities in patients with atopic dermatitis and psoriasis

Abstract

Atopic dermatitis (AD), a skin disease with an estimated lifetime prevalence of up to 20%, represents a major global healthcare burden.¹ Patients with AD have a propensity to develop asthma due to a combination of genetic, immunological and environmental factors, yet descriptive studies on the impact of respiratory diseases in adults with AD are scarce.² In contrast, psoriasis, another chronic inflammatory skin disease, has been associated with respiratory comorbidities such as chronic obstructive pulmonary disease (COPD)³, asthma⁴ and obstructive sleep apnea (OSA).

This article is protected by copyright. All rights reserved.

http://ift.tt/2ngYn3Y


http://ift.tt/2mUMLjB